Pulmonary Thromboembolism
12
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
The PERSEVERE Study
The PEERLESS Study
Computed Tomography CT Venography During Postpartum Venous Thromboembolism
Promotion of Active Lifestyle in Thromboembolism Patients
The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System
Thromboembolic Events in Severe COVID-19 Patients
Obstructive Sleep Apnea in Pulmonary Embolism
Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE
Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation
Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)